IBEX
Live / Registered — Registered (as of 28 Jun 2022)
What this means for you
Registered since 28 Jun 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87919745
- Registration number
- 6775112
- Mark type
- Stylized text
- Filed
- 14 May 2018
- Published for opposition
- 09 Nov 2021
- Registered
- 28 Jun 2022
- Attorney of record
- Michael H. Jacobs
Goods and services
- Class 042 — Scientific and technological services: Research and development of new biomedical products, namely, research and development in the field of biomedical and biotechnology research; biomedical research services; biotechnology research; scientific research for medical purposes in the field of pre-clinical research; providing assistance in pre- clinical study design and clinical trial preparation; none of the foregoing relating to the design and development of pharmaceutical production facilities, or bioprocessing and biomanufacturing facilities for the life sciences industry
Owner
- IBEX PRECLINICAL RESEARCH, INC., LOGAN, UT, US
- IBEX PRECLINICAL RESEARCH, INC., LOGAN, UT, US
- PolarityTE, Inc., Salt Lake City, UT, US
- PolarityTE, Inc., Salt Lake City, UT, US
Prosecution history
- 04 Oct 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 04 Oct 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 04 Oct 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 28 Jun 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 28 Jun 2022 — REGISTERED-PRINCIPAL REGISTER
- 27 May 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 26 May 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 20 May 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 20 May 2022 — NON-FINAL ACTION E-MAILED
- 20 May 2022 — SU - NON-FINAL ACTION - WRITTEN
- 02 May 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 14 Apr 2022 — USE AMENDMENT FILED
- 28 Apr 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 20 Apr 2022 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 14 Apr 2022 — TEAS STATEMENT OF USE RECEIVED